Scott Gottlieb, who led the FDA during Donald Trump’s first presidency, made waves by opposing Robert F. Kennedy Jr.’s nomination for health secretary. Gottlieb was among Trump’s most popular appointees in his first administration, gaining favor from lawmakers of both parties before leaving the post in 2019. Known for his science commentary during the Covid pandemic, Gottlieb is still a frequent presence on CNBC. Gottlieb is a longtime partner at New Enterprises Associates and a board member of both Pfizer and Illumina.
From STAT:
Former FDA commissioner Scott Gottlieb questions RFK Jr.’s measles response, infant formula plan
Former Trump FDA chief is seeking to undermine RFK Jr.’s Senate confirmation
Industry
Location
-
New York, N.Y.
